Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

169
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
169
Analgesia and Pain Management01:25

Analgesia and Pain Management

395
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
395
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

133
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
133
Drug Therapy01:28

Drug Therapy

28
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
28
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

313
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
313
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

147
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
147

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetic vs stapled technique in jejuno-ileal bipartition: one-year outcomes.

Surgical endoscopy·2026
Same author

PERCC1-associated enteropathy: Diagnostic challenges and enteral autonomy achieved with teduglutide.

JPGN reports·2026
Same author

Defining the Social Needs Service Cascade: Evidence From A Multistakeholder Qualitative Study.

Medical care research and review : MCRR·2026
Same author

HCMR's contributions to the study of AI in health care organizations.

Health care management review·2026
Same author

Factors associated with high-cost patients with first-episode psychosis: a retrospective study of direct healthcare costs using US private-payer claims data.

BMJ open·2026
Same author

Collaborative Management of Opioid Use Disorder and Cancer Care in a Patient With Medical Complexity and Housing Instability.

Cureus·2026
Same journal

The BELONG framework: An LGBTQIA+-inclusive suicide prevention gatekeeper training.

Psychological services·2026
Same journal

The impact of a psychological support service on the mental well-being, stress, and burnout of U.K.-based health care professionals: A multiple-methods service evaluation.

Psychological services·2026
Same journal

Potential agency and supervisor solutions to address burnout: Insights from clinicians in community mental health agencies across Washington State.

Psychological services·2026
Same journal

Tailored weight loss programs for adults with serious mental illness: 12-month follow-up of a randomized clinical trial of CoachToFit.

Psychological services·2026
Same journal

Longitudinal relations between parental burden, adolescent externalizing symptoms, and mental health service use in the year following adolescent psychiatric hospitalization.

Psychological services·2026
Same journal

"We worked … as if nothing was happening": Exploring multilevel burnout experiences and resources among health professionals in the context of compounding disasters in Puerto Rico.

Psychological services·2026
See all related articles

Related Experiment Video

Updated: May 9, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K

The System-Wide Medication for Opioid Use Disorder (SW-MOUD) program: A description of program implementation.

Brian P O'Rourke1, Tory H Hogan1, Alison Miller2

  • 1Division of Health Services Management and Policy, College of Public Health, Ohio State University.

Psychological Services
|May 5, 2025
PubMed
Summary
This summary is machine-generated.

Medication for opioid use disorder (MOUD) treatment access is limited. The System-Wide MOUD (SW-MOUD) program expanded MOUD access across settings and coordinated care, initiating 4,908 treatments in four years.

More Related Videos

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K

Related Experiment Videos

Last Updated: May 9, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K

Area of Science:

  • Health Services Research
  • Addiction Medicine
  • Public Health

Background:

  • Medication for opioid use disorder (MOUD) is effective but underutilized.
  • Access barriers and fragmented care limit MOUD for opioid use disorder (OUD).
  • Traditional MOUD programs operate in silos, hindering comprehensive patient care.

Purpose of the Study:

  • To describe the implementation of the System-Wide MOUD (SW-MOUD) program.
  • To serve as a roadmap for other health systems to expand MOUD access.
  • To improve continuous care for patients with OUD across healthcare settings.

Main Methods:

  • Designed and implemented the SW-MOUD program across emergency, inpatient, and outpatient settings.
  • Integrated program staff to coordinate patient care across different healthcare levels.
  • Utilized a patient flow model, implementation timeline, and phased strategies (preparation, rollout, sustainability).

Main Results:

  • The SW-MOUD program achieved 4,908 MOUD initiations in its first four years.
  • The program expanded MOUD access across diverse clinical settings.
  • Integrated care coordination was established across the health system.

Conclusions:

  • Systematic delivery approaches can transform evidence-based treatments into improved patient outcomes.
  • The SW-MOUD program provides a model for increasing MOUD access and coordinated care.
  • This approach can be adapted to expand access for various treatment modalities by integrating care across system silos.